Follow us on:

Advanced Oncotherapy Current EV significantly below cumulative investment to date (VIDEO)

Advanced Oncotherapy (LON:AVO) is the topic of conversation when Dr Martin Hall, Analyst at Hardman & Co joins DirectorsTalk.

Martin updates us on some of the recent developments at the company, explains why the share price is languishing, the demand for the project, shares his thoughts on the success of LIGHT and the company valuation.

Advanced Oncotherapy plc is a UK-based company focused on delivering a cost-effective proton-based radiotherapy solution called LIGHT. Based on ground-breaking technology developed and tested at world renowned CERN in Switzerland, the LIGHT system delivers an integrated proton radiotherapy system to treat cancer.

Share on:

You might also enjoy reading Volta Finance: Strong 2024, Positive 2025 outlook (LON:VTA)

Find more news, interviews, share price & company profile here for:

Hardman & Co

Other Interviews

Chesnara plc 20 Years of Dividend Growth Backed by £1.5 Billion Acquisition Surge (Video) May 2, 2025
Arbuthnot Banking Group Profits Dip but Franchise Growth Signals a Strategic Masterstroke (Video) April 25, 2025
NB Private Equity Partners Capital Shift, Trump and Interest Rate Tailwinds (Video) April 14, 2025
H&T Group 5 Growth Drivers Powering the UK’s Largest Pawnbroker (Video) April 7, 2025
accesso Technology Group Strong Recovery, Sharpened Strategy, and a Discount Valuation That Stands Out March 12, 2025
Real Estate Credit Investments – Private credit momentum in the RECI context (Video) February 27, 2025
Volta Finance Ltd: Can 2025 Outshine a Stellar 2024 Performance? (Video) February 26, 2025
Apax Global Alpha, Exits Surge as Market Demand Rebounds (Video) February 14, 2025
ICG Enterprise Trust, How a Unique Capital Strategy Drives Long-Term Investor Gains (Video) February 14, 2025
NB Private Equity Key Takeaway from Capital Markets Day (Video) December 3, 2024

More News

Chesnara: Strong Financial Resilience and Strategic Acquisition Growth (LON:CSN) May 6, 2025
Chesnara plc 20 Years of Dividend Growth Backed by £1.5 Billion Acquisition Surge (Video) May 2, 2025
Arbuthnot Banking Group: Franchise Growth and 2025 Outlook (LON:ARBB) May 1, 2025
Apax Global Alpha: Stronger prospects for 2025 and beyond (LON:APAX) May 1, 2025
NB Private Equity Partners: NAV Update, Capital Strategy & Market Outlook April 25, 2025
Surface Transforms Plc: Strategic Moves and Market Potential with Mike Foster September 3, 2024
Volta Finance What we can learn from the Report and Accounts (VIDEO) February 12, 2024
Real Estate Credit Investments – Actively managing the portfolio to the latest market opportunities (VIDEO) November 27, 2023
Structured products investing: Volta Finance in Hardman Q&A (LON:VTA) May 9, 2023
China investment opportunities: In-depth analysis of Fidelity China Special Situations (LON:FCSS) April 13, 2023

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2025 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.